down arrow

Ramsay Générale de Santé SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: FR0000044471
EUR
9.26
-0.02 (-0.22%)

Dec 12

PAR

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Clariane SE
Bastide Le Confort Medical SA
Ramsay Générale de Santé SA
MEDIAN Technologies SA
IntegraGen SA
Why is Ramsay Générale de Santé SA ?
1
With ROE of 2.87%, it has a Very Expensive valuation with a 0.93 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -19.48%, its profits have fallen by -72.4%
2
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -19.48% returns in the last 1 year, the stock has also underperformed France CAC 40 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Ramsay Générale de Santé SA for you?

Low Risk, Low Return

Absolute
Risk Adjusted
Volatility
Ramsay Générale de Santé SA
-19.48%
-1.99
25.20%
France CAC 40
8.73%
0.52
16.76%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
-3.51%
EBIT Growth (5y)
-16.81%
EBIT to Interest (avg)
5.18
Debt to EBITDA (avg)
2.87
Net Debt to Equity (avg)
1.79
Sales to Capital Employed (avg)
0.52
Tax Ratio
56.25%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
13.79%
ROE (avg)
14.46%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
32
Industry P/E
Price to Book Value
0.93
EV to EBIT
29.85
EV to EBITDA
13.95
EV to Capital Employed
0.97
EV to Sales
1.68
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
3.25%
ROE (Latest)
2.87%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Icon
Not enough Data to analyse Financial Trend
Icon
Not enough Data to analyse Financial Trend
Here's what is working for Ramsay Générale de Santé SA
Raw Material Cost
Fallen by -12.2% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Ramsay Générale de Santé SA
Pre-Tax Profit
At EUR -38.2 MM has Fallen at -270.87%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (EUR MM)

Net Profit
At EUR -38.7 MM has Fallen at -219.83%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (EUR MM)

Interest Coverage Ratio
Lowest at 262.9
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Net Profit
Lowest at EUR -38.7 MM and Fallen
In each period in the last five periods
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (EUR MM)

Operating Profit
Lowest at EUR 284.2 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (EUR MM)

Operating Profit Margin
Lowest at 11.34 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at EUR -38.2 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (EUR MM)

EPS
Lowest at EUR -0.39
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (EUR)

Debt-Equity Ratio
Highest at 334.43 %
in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."